Admission 2022

Admission Inquiry

Submit
Mr. Shashank Chaturvedi

Mr. Shashank Chaturvedi

  • Assistant Professor
    Institute of Pharmaceutical Research

  • Department

    Pharmaceutical Research

  • Experience

    10 years 5 months Teaching/Research experience in the field of Pharmaceutics

  • Qualifications

    • PhD (Persuing): Uttarakhand Technical University, Dehradun, Uttarakhand, India
    • M. Pharm. (Pharmaceutics) Hons.(2011): Gautam Buddh Technical University (Formerly UPTU) Lucknow U.P.
    • B. Pharm (Hons.) (2009): Uttar Pradesh Technical University Lucknow U.P.

     

  • Ph.D Thesis Supervised

    Postgraduate Thesis Supervised

  • Awarded/ Completed NIL

    WorkingNIL

  • Completed/ Awarded04

    WorkingNIL

  • 01Garg A. Chaturvedi S. (2021). A comprehensive review on chrysin: Emphasis on molecular targets, Pharmacological actions and Bio-pharmaceutical aspects. Current Drug Targets. DOI: 10.2174/1389450122666210824141044. Article ahead for print (SCI-Impact Factor-3.44)
  • 02Chaturvedi S, Garg A. (2021) An insight of techniques for the assessment of permeation flux across the skin for optimization of topical and transdermal drug delivery systems. Journal of Drug Delivery Science and Technology. 62: 102355. https://doi.org/10.1016/j.jddst.2021.102355 (SCI-Impact Factor- 3.89)
  • 03Chaturvedi S, Ayaz S, Shah K. (2021) Validated UV spectrophotometric method for in-vitro dissolution studies in phosphate buffer pH 7.4. International Journal of Pharmaceutical Science and Research. 12 (4): 2417-2421. doi: 10.13040/IJPSR.0975-8232.12(4).2417-21 (ESCI)
  • 04Sharma KD, Goyal A, Chaturvedi S. (2020) Dietary Inclusions and Exclusions: Preparation Against Cancer. Oncologie. 22 (4): 213-224, DOI: 10.32604/oncologie.2020.014926. (SCI-Impact Factor-0.33)
  • 05Chaturvedi S, Verma A, Saharan VA. (2020) Lipid Drug Carriers for Cancer Therapeutics: An Insight into Lymphatic Targeting, P-gp, CYP3A4 Modulation and Bioavailability Enhancement. Advanced Pharmaceutical Bulletin, 10 (4): 522-539, doi: 10.34172/apb.2020.064. (ESCI/Scopus)
  • 06Chaturvedi S, Garg A, Verma A. (2020) Nano lipid-based carriers for lymphatic voyage of anti-cancer drugs: An insight into the in-vitro, ex-vivo, in-situ and in-vivo study models. Journal of Drug Delivery Science and Technology. 59: 101899. https://doi.org/10.1016/j.jddst.2020.101899 (SCI-Impact Factor- 3.89)
  • 07Chaturvedi S, Alim M. (2020) Formulation and evaluation solid dispersion based fast dispersible tablets of Domperidone. International Journal of Pharmaceutical Research, 12 (4): https://doi.org/10.31838/ijpr/2020.12.04.019. (Scopus)
  • 08Chaturvedi S, Mishra R. (2020) Insight into Delivery Approaches for Biopharmaceutics Classification System Class II and IV Drugs. Drug Delivery letters, DOI: 10.2174/2210303110999200712185109 (Scopus).
  • 09Chaturvedi S, Alim M, Agrawal VK. (2017) Solubility and Dissolution Enhancement of Domperidone using 2-Hydroxypropyl-β-cyclodextrin by Kneading Method. Asian Journal of Pharmaceutics, 11 (3): 168-175. (ESCI/Scopus).
  • 10Editorial Article (2017) Generic drug prescription: Possible issues, impacts and consequences. Pharmatutor Magazine, 5 (5): 5-8.
  • 11Chaturvedi S, Alim M, Agrawal VK, Karna S. (2016) Swellable and Floating Gastroretentive Formulation for Sustained Delivery of Metformin HCl. International Journal of Pharmaceutical Science and Research; 7(4): 1590-02. doi: 10.13040/IJPSR.0975-8232.7(4).1590-02. (Scopus/ESCI)
  • 12Karna S, Chaturvedi S, Agrawal VK, Alim M. (2015) Formulation Approaches for Sustained Release Dosage Forms: A Review. Asian Journal of Pharmaceutical and Clinical Research. 8 (5): 34-41. (Scopus)
  • 13Chaturvedi S, Aleem M, Agrawal VK, Karna S. (2015) Validated UV Spectrophotometric method for the estimation of Domperidone for Dissolution Study in Der Pharmacia Letter, 7 (6): 53-58. (Scopus)
  • 14Chaturvedi S, Kumari P, Agrawal VK. (2013) Polysaccharides and gums as reservoir for a sustained delivery of tramadol HCl by hydro-dynamically balanced system.  International Journal of Pharmacy and Pharmaceutical Sciences. 6 (1): 753-757. (Scopus)
  • 15Chaturvedi S, Kumari P, Singh S, Agrawal VK. (2013) Approaches to increase the gastric residence time: floating drug delivery systems- A Review. Asian Journal of Pharmaceutical Clinical Research. 6 (3): 1-9. (Scopus)
  • 16Chaturvedi S, Agrawal VK, Singh S. (2012) Impact of Superdisintegrant on the release of Oro-Dispersible Tablets of Losartan Potassium: A Comparative Analysis. Der Pharmacia Letter. Volume 4 (6): 1768-1776. (Scopus)
  • 17Singh S, Patel K, Agrawal VK, Chaturvedi S. (2012) Stability indicating HPTLC method for simultaneous determination of Valsartan and Hydrochlorothiazide in tablets. International Journal of Pharmacy and Pharmaceutical Sciences. 4 (4): 76-77. (Scopus)
  • 18Singh S, Patel K, Agrawal VK, Chaturvedi S. (2012) Simultaneous estimation of S (-) Amlodipine Besylate Hemipentahydrate and Losartan Potassium in Combined Dosage Form by Using UV-Spectroscopy. Der Pharmacia Letter. 4 (3):  897-905. (Scopus)
  • 19Chaturvedi S, Agrawal VK, Verma A, Verma N, Singh S. (2012) Comparative evaluation of natural and semi synthetic superdisintegrants in the formulation of orodispersible tablets of Norfloxacin. International Journal of Pharmacy and Pharmaceutical Sciences. 4 (3): 576-583. (Scopus)
  • 20Agrawal VK, Gupta A, Chaturvedi S. (2012) Improvement in bioavailability of Class-III drug: Phytolipid delivery system. International Journal of Pharmacy and Pharmaceutical Sciences. 4 (1): 37-42. (Scopus)

Conferences(Abstract)

  • 01Oral presentation on “A Comprehensive Review on Nano Formulations Containing Exemestane” in 1st International Conference on “Innovations in Chemical, Biological and Pharmaceutical Sciences (ICBPS-2021)” held at Institute of Pharmaceutical Research, GLA University, Mathura on November 26-27, 2021 through online mode.
  • 02Presented a poster on “Formulation and Evaluation of Terbinafine Hydrochloride Oro-dispersible tablet for the treatment of Onychomycosis” in 5th International Symposium (CTDDR-2013) at CSIR-CDRI Lucknow, (U.P.).
  • 03Oral presentation on “Formulation and In-vitro Evaluation of HBS of Tramadol HCl delivery” in a National Conference at Globus College of Pharmacy, Bhopal on 2013.
  • 04Presented a poster on “Comparative Evaluation of Natural and Semi-synthetic Super-disintegrants in the formulation of BCS Class IV Fast Disintegrating Tablets” in a National Conference by SPER at DIPSR-2012.
  • 05Presented a poster on “Development and Evaluation of Norfloxacin Taste masked Oro-Dispersible Tablets” in an ICMR sponsored National Seminar at GRKIST, Jabalpur, M.P. 2012
  • 06Presented a poster on “Preparation and evaluation of Buccal Films of Metoprolol: In –vitro performance and effect of ageing” in a National Seminar at S.G.I.T Ghaziabad (2010) and bagged first prize in the same.

Book Chapters

  • 01Chaturvedi S, Pathak K (2021) Nanoparticulate systems and their translation potential for breast cancer therapeutics, Editor(s): Kamal Dua, Meenu Mehta, Terezinha de Jesus Andreoli Pinto, Lisa G. Pont, Kylie A. Williams, Michael J. Rathbone, Advanced Drug Delivery Systems in the Management of Cancer, Academic Press, 2021, Pages 299-318, ISBN 9780323855037, https://doi.org/10.1016/B978-0-323-85503-7.00021-3.

Patents

  • 01Garg A, Goyal A, Chaturvedi S (2020) Nanoemulgel composition containing essential oil of Ferula asafoetida. Indian Patent, published on 11.12.2020.
  • 02Chaturvedi S, Garg A, Gandhi M (2021) Oil-in-water emulsion cosmetic composition. Indian Patent, published on 17.12.2021
  • 01Attended e-FDP on “Advances in Herbal Formulations” from June 30-July 4, 2021 at Institute of Pharmaceutical Research, GLA University, Mathura, U.P., India.
  • 02Attended a SPARC sponsored Indo-US workshop on “Pain Mechanism & Therapeutics” held from 06-10 May 2021 at Department of Pharmaceutical Engineering & Technology, Indian Institute of Technology (Banaras Hindu University), Varanasi, U.P India.
  • 03Attended UGC sponsored National Conference on “Quality Control of Indian Medicinal Plants-Standardised Raw Material to finished products” held from 25-26 March 2021 at Department of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak, Haryana. India
  • 04Attended AICTE sponsored e-Conference on “Personalized Drug Delivery Through 3-D Printing: Newer Challenges for Pharma Industries held from 25-27 November 2020 at Noida Institute of Engineering and Technology (Pharmacy Institute), Great Noida, U.P. India.
  • 05Attended of e-fdp on Advances in Pharmaceutical Research from 21-26 August 2020 at Institute of Pharmaceutical Research, GLA University, Mathura, U.P., India.
  • 06Completed six weeks online certificate course on “Learning to Teach Online” authorized by UNSW Sydney (The University of New South Wales) and offered through Coursera on 18-06-2020.
  • 07Completed six weeks online certificate course on “Herbal Medicine” authorized by University of Minnesota and offered through Coursera on 12-05-2020.
  • 08Attended One-Week National Level e-FDP on “Redefining the Role of Educator in Covid-19 Outbreak Era” Jointly organized by Gujarat Technological University, Ahmedabad and Anand Pharmacy college, Anand, Gujarat during 11-16 May, 2020.
  • 09Completed four weeks course on “Biomedical Nanotechnology” offered by NPTEL-AICTE from Aug-Sep 2019.
  • 10Completed 15 days AICTE sponsored Quality Improvement Programme (QIP) on “Biotechniques in Drug Delivery: Trends and Applications” Pharmaceutics Division organized by BIT-Mesra, Ranchi from 16-06-2017 to 29-06-2017.
  • Association of Pharmacy Teachers in India (APTI)- Life member (Membership No. UP/LM-591)
  • Life Time member of Association of Pharmacy Professionals [APP/UP/LM-015/12]

Credentials

  • Registered Pharmacist in Uttar Pradesh Pharmacy Council, Lucknow, Certificate No. 49282.

Achievements

  • Qualified GPAT 2013.
  • Qualified Gate (Pharmacy) 2009